Sutro Biopharma Inc (STRO)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
Nov 22, 16:00
2.52
+0.01
(+0.40%)
After-Hours: 20:00
Sutro Biopharma Total Liabilities (Quarterly): 340.61M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 340.61M |
| June 30, 2024 | 336.87M |
| March 31, 2024 | 305.38M |
| December 31, 2023 | 321.09M |
| September 30, 2023 | 319.39M |
| June 30, 2023 | 310.18M |
| March 31, 2023 | 172.60M |
| December 31, 2022 | 189.90M |
| September 30, 2022 | 170.97M |
| June 30, 2022 | 176.56M |
| March 31, 2022 | 83.30M |
| December 31, 2021 | 88.84M |
| September 30, 2021 | 87.89M |
| June 30, 2021 | 52.29M |
| Date | Value |
|---|---|
| March 31, 2021 | 51.19M |
| December 31, 2020 | 62.06M |
| September 30, 2020 | 63.12M |
| June 30, 2020 | 70.78M |
| March 31, 2020 | 71.79M |
| December 31, 2019 | 58.58M |
| September 30, 2019 | 61.77M |
| June 30, 2019 | 69.26M |
| March 31, 2019 | 71.74M |
| December 31, 2018 | 91.60M |
| September 30, 2018 | 286.46M |
| June 30, 2018 | 177.20M |
| December 31, 2017 | 149.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
51.19M
Minimum
Mar 2021
340.61M
Maximum
Sep 2024
166.67M
Average
129.91M
Median
Total Liabilities (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 21.72M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 451.83M |
| Shareholders Equity (Quarterly) | 111.22M |
| Current Ratio | 3.091 |
| Net Debt Paydown Yield | 0.72% |